Used in pharmaceutical research as a key intermediate in the synthesis of biologically active compounds, particularly in the development of kinase inhibitors and central nervous system agents. Its structure supports binding to specific enzyme targets, making it valuable in drug discovery for oncology and neurological disorders. Also employed in the optimization of metabolic stability and bioavailability in lead compounds due to the presence of the trifluoromethyl group.